TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC
Conference Call and Webcast Information
The Company will host a conference call, Tuesday, December 19, 2023, at 8:30 AM Eastern Time, to discuss initial data from its ongoing Phase 2 trials of TFF VORI and TFF TAC.